FDA cleared the Affinity from Hermes Medical Solutions AB on Jul 31, 2026 under K253835, a traditional 510(k). The device falls under product code QIH, Automated Radiological Image Processing Software, regulated at 21 CFR 892.2050 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on Dec 1, 2025. The decision came 242 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Hermes Medical Solutions AB in the last 12 months of the tracker.